Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Activation of KIF4A as a prognostic biomarker and therapeutic target for lung cancer.

Taniwaki M, Takano A, Ishikawa N, Yasui W, Inai K, Nishimura H, Tsuchiya E, Kohno N, Nakamura Y, Daigo Y. Activation of KIF4A as a prognostic biomarker and therapeutic target for lung cancer. Clin Cancer Res. 2007 Nov 15; 13(22 Pt 1):6624-31.

View in: PubMed

collapse authors with profiles